Abstract
Denervation, disuse, fasting, and various diseases could induce skeletal muscle atrophy, which results in the decline of life quality and increase of the mortality risk for patients. Noncoding RNAs (ncRNAs) are implicated important in regulating gene expression. Thus, ncRNAs, especially microRNAs and long noncoding RNAs (lncRNAs), have gained widespread attention as crucial players in numerous physiological and pathological processes, including skeletal muscle atrophy. In this review, we comprehensively described the potential of circulating microRNAs as biomarkers, summarized the profiling of microRNAs and lncRNAs in atrophying muscles, as well as discussed the effects and underlying mechanisms of microRNA machinery proteins, microRNAs, and lncRNAs in skeletal muscle atrophy. Considering the large quantity and variety of ncRNAs, the understanding of ncRNAs in muscle atrophy is still very limited. Future studies are needed to elucidate the possibility of ncRNAs as diagnosis biomarkers and therapeutic targets in muscle atrophy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ruegg MA, Glass DJ (2011) Molecular mechanisms and treatment options for muscle wasting diseases. Annu Rev Pharmacol Toxicol 51:373–395. https://doi.org/10.1146/annurev-pharmtox-010510-100537
Mizuno H, Nakamura A, Aoki Y, Ito N, Kishi S, Yamamoto K, Sekiguchi M, Takeda S, Hashido K (2011) Identification of muscle-specific microRNAs in serum of muscular dystrophy animal models: promising novel blood-based markers for muscular dystrophy. PLoS One 6(3):e18388. https://doi.org/10.1371/journal.pone.0018388
Perfetti A, Greco S, Bugiardini E, Cardani R, Gaia P, Gaetano C, Meola G, Martelli F (2014) Plasma microRNAs as biomarkers for myotonic dystrophy type 1. Neuromuscul Disord 24(6):509–515. https://doi.org/10.1016/j.nmd.2014.02.005
Wang XH, Du J, Klein JD, Bailey JL, Mitch WE (2009) Exercise ameliorates chronic kidney disease-induced defects in muscle protein metabolism and progenitor cell function. Kidney Int 76(7):751–759. https://doi.org/10.1038/ki.2009.260
Gordon BS, Kelleher AR, Kimball SR (2013) Regulation of muscle protein synthesis and the effects of catabolic states. Int J Biochem Cell Biol 45(10):2147–2157. https://doi.org/10.1016/j.biocel.2013.05.039
Bonaldo P, Sandri M (2013) Cellular and molecular mechanisms of muscle atrophy. Dis Model Mech 6(1):25–39. https://doi.org/10.1242/dmm.010389
Stephens NA, Gallagher IJ, Rooyackers O, Skipworth RJ, Tan BH, Marstrand T, Ross JA, Guttridge DC, Lundell L, Fearon KC, Timmons JA (2010) Using transcriptomics to identify and validate novel biomarkers of human skeletal muscle cancer cachexia. Genome Med 2(1):1. https://doi.org/10.1186/gm122
von Haehling S, Ebner N, Dos Santos MR, Springer J, Anker SD (2017) Muscle wasting and cachexia in heart failure: mechanisms and therapies. Nat Rev Cardiol 14(6):323–341. https://doi.org/10.1038/nrcardio.2017.51
Yu Y, Li X, Liu L, Chai J, Haijun Z, Chu W, Yin H, Ma L, Duan H, Xiao M (2016) miR-628 promotes burn-induced skeletal muscle atrophy via targeting IRS1. Int J Biol Sci 12(10):1213–1224. https://doi.org/10.7150/ijbs.15496
Haijun Z, Yonghui Y, Jiake C, Hongjie D (2015) Detection of the MicroRNA expression profile in skeletal muscles of burn trauma at the early stage in rats. Ulus Travma Acil Cerrahi Derg 21(4):241–247. https://doi.org/10.5505/tjtes.2015.80707
Verdijk LB, Dirks ML, Snijders T, Prompers JJ, Beelen M, Jonkers RA, Thijssen DH, Hopman MT, Van Loon LJ (2012) Reduced satellite cell numbers with spinal cord injury and aging in humans. Med Sci Sports Exerc 44(12):2322–2330. https://doi.org/10.1249/MSS.0b013e3182667c2e
Gao Y, Arfat Y, Wang H, Goswami N (2018) Muscle atrophy induced by mechanical unloading: mechanisms and potential countermeasures. Front Physiol 9:235. https://doi.org/10.3389/fphys.2018.00235
Cohen S, Nathan JA, Goldberg AL (2015) Muscle wasting in disease: molecular mechanisms and promising therapies. Nat Rev Drug Discov 14(1):58–74. https://doi.org/10.1038/nrd4467
Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136(2):215–233. https://doi.org/10.1016/j.cell.2009.01.002
Shukla GC, Singh J, Barik S (2011) MicroRNAs: processing, maturation, target recognition and regulatory functions. Mol Cell Pharmacol 3(3):83–92
Kim VN (2005) MicroRNA biogenesis: coordinated cropping and dicing. Nat Rev Mol Cell Biol 6(5):376–385. https://doi.org/10.1038/nrm1644
Yates LA, Norbury CJ, Gilbert RJ (2013) The long and short of microRNA. Cell 153(3):516–519. https://doi.org/10.1016/j.cell.2013.04.003
Chekulaeva M, Filipowicz W (2009) Mechanisms of miRNA-mediated post-transcriptional regulation in animal cells. Curr Opin Cell Biol 21(3):452–460. https://doi.org/10.1016/j.ceb.2009.04.009
Carthew RW, Sontheimer EJ (2009) Origins and mechanisms of miRNAs and siRNAs. Cell 136(4):642–655. https://doi.org/10.1016/j.cell.2009.01.035
O’Rourke JR, Georges SA, Seay HR, Tapscott SJ, McManus MT, Goldhamer DJ, Swanson MS, Harfe BD (2007) Essential role for Dicer during skeletal muscle development. Dev Biol 311(2):359–368. https://doi.org/10.1016/j.ydbio.2007.08.032
Haramati S, Chapnik E, Sztainberg Y, Eilam R, Zwang R, Gershoni N, McGlinn E, Heiser PW, Wills AM, Wirguin I, Rubin LL, Misawa H, Tabin CJ, Brown R Jr, Chen A, Hornstein E (2010) miRNA malfunction causes spinal motor neuron disease. Proc Natl Acad Sci U S A 107(29):13111–13116. https://doi.org/10.1073/pnas.1006151107
Neppl RL, Kataoka M, Wang DZ (2014) Crystallin-alphaB regulates skeletal muscle homeostasis via modulation of argonaute2 activity. J Biol Chem 289(24):17240–17248. https://doi.org/10.1074/jbc.M114.549584
Sakamoto S, Aoki K, Higuchi T, Todaka H, Morisawa K, Tamaki N, Hatano E, Fukushima A, Taniguchi T, Agata Y (2009) The NF90-NF45 complex functions as a negative regulator in the microRNA processing pathway. Mol Cell Biol 29(13):3754–3769. https://doi.org/10.1128/MCB.01836-08
Todaka H, Higuchi T, Yagyu K, Sugiyama Y, Yamaguchi F, Morisawa K, Ono M, Fukushima A, Tsuda M, Taniguchi T, Sakamoto S (2015) Overexpression of NF90-NF45 represses myogenic MicroRNA biogenesis, resulting in development of skeletal muscle atrophy and centronuclear muscle fibers. Mol Cell Biol 35(13):2295–2308. https://doi.org/10.1128/MCB.01297-14
Wang GK, Zhu JQ, Zhang JT, Li Q, Li Y, He J, Qin YW, Jing Q (2010) Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J 31(6):659–666. https://doi.org/10.1093/eurheartj/ehq013
Cacchiarelli D, Legnini I, Martone J, Cazzella V, D’Amico A, Bertini E, Bozzoni I (2011) miRNAs as serum biomarkers for Duchenne muscular dystrophy. EMBO Mol Med 3(5):258–265. https://doi.org/10.1002/emmm.201100133
Koutsoulidou A, Kyriakides TC, Papadimas GK, Christou Y, Kararizou E, Papanicolaou EZ, Phylactou LA (2015) Elevated muscle-specific miRNAs in serum of myotonic dystrophy patients relate to muscle disease progress. PLoS One 10(4):e0125341. https://doi.org/10.1371/journal.pone.0125341
Lewis A, Riddoch-Contreras J, Natanek SA, Donaldson A, Man WD, Moxham J, Hopkinson NS, Polkey MI, Kemp PR (2012) Downregulation of the serum response factor/miR-1 axis in the quadriceps of patients with COPD. Thorax 67(1):26–34. https://doi.org/10.1136/thoraxjnl-2011-200309
Wang F, Wang J, He J, Li W, Li J, Chen S, Zhang P, Liu H, Chen X (2017) Serum miRNAs miR-23a, 206, and 499 as potential biomarkers for skeletal muscle atrophy. Biomed Res Int 2017:8361237. https://doi.org/10.1155/2017/8361237
Catapano F, Zaharieva I, Scoto M, Marrosu E, Morgan J, Muntoni F, Zhou H (2016) Altered levels of MicroRNA-9, −206, and −132 in spinal muscular atrophy and their response to antisense oligonucleotide therapy. Mol Ther Nucleic Acids 5(7):e331. https://doi.org/10.1038/mtna.2016.47
Soares RJ, Cagnin S, Chemello F, Silvestrin M, Musaro A, De Pitta C, Lanfranchi G, Sandri M (2014) Involvement of microRNAs in the regulation of muscle wasting during catabolic conditions. J Biol Chem 289(32):21909–21925. https://doi.org/10.1074/jbc.M114.561845
Eisenberg I, Eran A, Nishino I, Moggio M, Lamperti C, Amato AA, Lidov HG, Kang PB, North KN, Mitrani-Rosenbaum S, Flanigan KM, Neely LA, Whitney D, Beggs AH, Kohane IS, Kunkel LM (2007) Distinctive patterns of microRNA expression in primary muscular disorders. Proc Natl Acad Sci U S A 104(43):17016–17021. https://doi.org/10.1073/pnas.0708115104
Fritegotto C, Ferrati C, Pegoraro V, Angelini C (2017) Micro-RNA expression in muscle and fiber morphometry in myotonic dystrophy type 1. Neurol Sci 38(4):619–625. https://doi.org/10.1007/s10072-017-2811-2
Zhang J, Fu SL, Liu Y, Liu YL, Wang WJ (2015) Analysis of MicroRNA expression profiles in weaned pig skeletal muscle after lipopolysaccharide challenge. Int J Mol Sci 16(9):22438–22455. https://doi.org/10.3390/ijms160922438
Hauser CA, Stockler MR, Tattersall MH (2006) Prognostic factors in patients with recently diagnosed incurable cancer: a systematic review. Support Care Cancer 14(10):999–1011. https://doi.org/10.1007/s00520-006-0079-9
Lee DE, Brown JL, Rosa-Caldwell ME, Blackwell TA, Perry RA Jr, Brown LA, Khatri B, Seo D, Bottje WG, Washington TA, Wiggs MP, Kong BW, Greene NP (2017) Cancer cachexia-induced muscle atrophy: evidence for alterations in microRNAs important for muscle size. Physiol Genomics 49(5):253–260. https://doi.org/10.1152/physiolgenomics.00006.2017
Khayrullin A, Smith L, Mistry D, Dukes A, Pan YA, Hamrick MW (2016) Chronic alcohol exposure induces muscle atrophy (myopathy) in zebrafish and alters the expression of microRNAs targeting the Notch pathway in skeletal muscle. Biochem Biophys Res Commun 479(3):590–595. https://doi.org/10.1016/j.bbrc.2016.09.117
Weng J, Zhang P, Yin X, Jiang B (2018) The whole transcriptome involved in denervated muscle atrophy following peripheral nerve injury. Front Mol Neurosci 11:69. https://doi.org/10.3389/fnmol.2018.00069
Li G, Li QS, Li WB, Wei J, Chang WK, Chen Z, Qiao HY, Jia YW, Tian JH, Liang BS (2016) miRNA targeted signaling pathway in the early stage of denervated fast and slow muscle atrophy. Neural Regen Res 11(8):1293–1303. https://doi.org/10.4103/1673-5374.189195
Di Pietro L, Baranzini M, Berardinelli MG, Lattanzi W, Monforte M, Tasca G, Conte A, Logroscino G, Michetti F, Ricci E, Sabatelli M, Bernardini C (2017) Potential therapeutic targets for ALS: MIR206, MIR208b and MIR499 are modulated during disease progression in the skeletal muscle of patients. Sci Rep 7(1):9538. https://doi.org/10.1038/s41598-017-10161-z
Waller R, Goodall EF, Milo M, Cooper-Knock J, Da Costa M, Hobson E, Kazoka M, Wollff H, Heath PR, Shaw PJ, Kirby J (2017) Serum miRNAs miR-206, 143-3p and 374b-5p as potential biomarkers for amyotrophic lateral sclerosis (ALS). Neurobiol Aging 55:123–131. https://doi.org/10.1016/j.neurobiolaging.2017.03.027
Kovanda A, Leonardis L, Zidar J, Koritnik B, Dolenc-Groselj L, Ristic Kovacic S, Curk T, Rogelj B (2018) Differential expression of microRNAs and other small RNAs in muscle tissue of patients with ALS and healthy age-matched controls. Sci Rep 8(1):5609. https://doi.org/10.1038/s41598-018-23139-2
Boon H, Sjogren RJ, Massart J, Egan B, Kostovski E, Iversen PO, Hjeltnes N, Chibalin AV, Widegren U, Zierath JR (2015) MicroRNA-208b progressively declines after spinal cord injury in humans and is inversely related to myostatin expression. Physiol Rep 3(11). https://doi.org/10.14814/phy2.12622
Shen H, Liu T, Fu L, Zhao S, Fan B, Cao J, Li X (2013) Identification of microRNAs involved in dexamethasone-induced muscle atrophy. Mol Cell Biochem 381(1–2):105–113. https://doi.org/10.1007/s11010-013-1692-9
Liu C, Wang M, Chen M, Zhang K, Gu L, Li Q, Yu Z, Li N, Meng Q (2017) miR-18a induces myotubes atrophy by down-regulating IgfI. Int J Biochem Cell Biol 90:145–154. https://doi.org/10.1016/j.biocel.2017.07.020
Hudson MB, Rahnert JA, Zheng B, Woodworth-Hobbs ME, Franch HA, Price SR (2014) miR-182 attenuates atrophy-related gene expression by targeting FoxO3 in skeletal muscle. Am J Physiol Cell Physiol 307(4):C314–C319. https://doi.org/10.1152/ajpcell.00395.2013
Kennedy WR, Alter M, Sung JH (1998) Progressive proximal spinal and bulbar muscular atrophy of late onset: a sex-linked recessive trait. Neurology 50(3): 583 and 510 pages following
La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH (1991) Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 352(6330):77–79. https://doi.org/10.1038/352077a0
Sobue G, Hashizume Y, Mukai E, Hirayama M, Mitsuma T, Takahashi A (1989) X-linked recessive bulbospinal neuronopathy. A clinicopathological study. Brain 112(Pt 1):209–232
Miyazaki Y, Adachi H, Katsuno M, Minamiyama M, Jiang YM, Huang Z, Doi H, Matsumoto S, Kondo N, Iida M, Tohnai G, Tanaka F, Muramatsu S, Sobue G (2012) Viral delivery of miR-196a ameliorates the SBMA phenotype via the silencing of CELF2. Nat Med 18(7):1136–1141. https://doi.org/10.1038/nm.2791
Pourshafie N, Lee PR, Chen KL, Harmison GG, Bott LC, Katsuno M, Sobue G, Burnett BG, Fischbeck KH, Rinaldi C (2016) MiR-298 counteracts mutant androgen receptor toxicity in spinal and bulbar muscular atrophy. Mol Ther 24(5):937–945. https://doi.org/10.1038/mt.2016.13
Kukreti H, Amuthavalli K, Harikumar A, Sathiyamoorthy S, Feng PZ, Anantharaj R, Tan SL, Lokireddy S, Bonala S, Sriram S, McFarlane C, Kambadur R, Sharma M (2013) Muscle-specific microRNA1 (miR1) targets heat shock protein 70 (HSP70) during dexamethasone-mediated atrophy. J Biol Chem 288(9):6663–6678. https://doi.org/10.1074/jbc.M112.390369
McCarthy JJ, Esser KA, Peterson CA, Dupont-Versteegden EE (2009) Evidence of MyomiR network regulation of beta-myosin heavy chain gene expression during skeletal muscle atrophy. Physiol Genomics 39(3):219–226. https://doi.org/10.1152/physiolgenomics.00042.2009
Chen JF, Mandel EM, Thomson JM, Wu Q, Callis TE, Hammond SM, Conlon FL, Wang DZ (2006) The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet 38(2):228–233. https://doi.org/10.1038/ng1725
Huang MB, Xu H, Xie SJ, Zhou H, Qu LH (2011) Insulin-like growth factor-1 receptor is regulated by microRNA-133 during skeletal myogenesis. PLoS One 6(12):e29173. https://doi.org/10.1371/journal.pone.0029173
He Q, Qiu J, Dai M, Fang Q, Sun X, Gong Y, Ding F, Sun H (2016) MicroRNA-351 inhibits denervation-induced muscle atrophy by targeting TRAF6. Exp Ther Med 12(6):4029–4034. https://doi.org/10.3892/etm.2016.3856
Huang QK, Qiao HY, Fu MH, Li G, Li WB, Chen Z, Wei J, Liang BS (2016) MiR-206 attenuates denervation-induced skeletal muscle atrophy in rats through regulation of satellite cell differentiation via TGF-beta1, Smad3, and HDAC4 signaling. Med Sci Monit 22:1161–1170
Williams AH, Valdez G, Moresi V, Qi X, McAnally J, Elliott JL, Bassel-Duby R, Sanes JR, Olson EN (2009) MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice. Science 326(5959):1549–1554. https://doi.org/10.1126/science.1181046
Connolly M, Paul R, Farre-Garros R, Natanek SA, Bloch S, Lee J, Lorenzo JP, Patel H, Cooper C, Sayer AA, Wort SJ, Griffiths M, Polkey MI, Kemp PR (2018) miR-424-5p reduces ribosomal RNA and protein synthesis in muscle wasting. J Cachexia Sarcopenia Muscle 9(2):400–416. https://doi.org/10.1002/jcsm.12266
Li J, Chan MC, Yu Y, Bei Y, Chen P, Zhou Q, Cheng L, Chen L, Ziegler O, Rowe GC, Das S, Xiao J (2017) miR-29b contributes to multiple types of muscle atrophy. Nat Commun 8:15201. https://doi.org/10.1038/ncomms15201
Wang B, Zhang C, Zhang A, Cai H, Price SR, Wang XH (2017) MicroRNA-23a and MicroRNA-27a mimic exercise by ameliorating CKD-induced muscle atrophy. J Am Soc Nephrol 28(9):2631–2640. https://doi.org/10.1681/ASN.2016111213
Wada S, Kato Y, Okutsu M, Miyaki S, Suzuki K, Yan Z, Schiaffino S, Asahara H, Ushida T, Akimoto T (2011) Translational suppression of atrophic regulators by microRNA-23a integrates resistance to skeletal muscle atrophy. J Biol Chem 286(44):38456–38465. https://doi.org/10.1074/jbc.M111.271270
Hudson MB, Woodworth-Hobbs ME, Zheng B, Rahnert JA, Blount MA, Gooch JL, Searles CD, Price SR (2014) miR-23a is decreased during muscle atrophy by a mechanism that includes calcineurin signaling and exosome-mediated export. Am J Physiol Cell Physiol 306(6):C551–C558. https://doi.org/10.1152/ajpcell.00266.2013
Devaux Y, Zangrando J, Schroen B, Creemers EE, Pedrazzini T, Chang CP, Dorn GW 2nd, Thum T, Heymans S (2015) Long noncoding RNAs in cardiac development and ageing. Nat Rev Cardiol 12(7):415–425. https://doi.org/10.1038/nrcardio.2015.55
Guttman M, Donaghey J, Carey BW, Garber M, Grenier JK, Munson G, Young G, Lucas AB, Ach R, Bruhn L, Yang X, Amit I, Meissner A, Regev A, Rinn JL, Root DE, Lander ES (2011) lincRNAs act in the circuitry controlling pluripotency and differentiation. Nature 477(7364):295–300. https://doi.org/10.1038/nature10398
Kapusta A, Feschotte C (2014) Volatile evolution of long noncoding RNA repertoires: mechanisms and biological implications. Trends Genet 30(10):439–452. https://doi.org/10.1016/j.tig.2014.08.004
Ulitsky I, Bartel DP (2013) lincRNAs: genomics, evolution, and mechanisms. Cell 154(1):26–46. https://doi.org/10.1016/j.cell.2013.06.020
Ebert MS, Neilson JR, Sharp PA (2007) MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat Methods 4(9):721–726. https://doi.org/10.1038/nmeth1079
Kino T, Hurt DE, Ichijo T, Nader N, Chrousos GP (2010) Noncoding RNA gas5 is a growth arrest- and starvation-associated repressor of the glucocorticoid receptor. Sci Signal 3(107):ra8. https://doi.org/10.1126/scisignal.2000568
Yin QF, Yang L, Zhang Y, Xiang JF, Wu YW, Carmichael GG, Chen LL (2012) Long noncoding RNAs with snoRNA ends. Mol Cell 48(2):219–230. https://doi.org/10.1016/j.molcel.2012.07.033
Hube F, Velasco G, Rollin J, Furling D, Francastel C (2011) Steroid receptor RNA activator protein binds to and counteracts SRA RNA-mediated activation of MyoD and muscle differentiation. Nucleic Acids Res 39(2):513–525. https://doi.org/10.1093/nar/gkq833
Caretti G, Schiltz RL, Dilworth FJ, Di Padova M, Zhao P, Ogryzko V, Fuller-Pace FV, Hoffman EP, Tapscott SJ, Sartorelli V (2006) The RNA helicases p68/p72 and the noncoding RNA SRA are coregulators of MyoD and skeletal muscle differentiation. Dev Cell 11(4):547–560. https://doi.org/10.1016/j.devcel.2006.08.003
Dey BK, Pfeifer K, Dutta A (2014) The H19 long noncoding RNA gives rise to microRNAs miR-675-3p and miR-675-5p to promote skeletal muscle differentiation and regeneration. Genes Dev 28(5):491–501. https://doi.org/10.1101/gad.234419.113
Mueller AC, Cichewicz MA, Dey BK, Layer R, Reon BJ, Gagan JR, Dutta A (2015) MUNC, a long noncoding RNA that facilitates the function of MyoD in skeletal myogenesis. Mol Cell Biol 35(3):498–513. https://doi.org/10.1128/MCB.01079-14
Gong C, Li Z, Ramanujan K, Clay I, Zhang Y, Lemire-Brachat S, Glass DJ (2015) A long non-coding RNA, LncMyoD, regulates skeletal muscle differentiation by blocking IMP2-mediated mRNA translation. Dev Cell 34(2):181–191. https://doi.org/10.1016/j.devcel.2015.05.009
Cesana M, Cacchiarelli D, Legnini I, Santini T, Sthandier O, Chinappi M, Tramontano A, Bozzoni I (2011) A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell 147(2):358–369. https://doi.org/10.1016/j.cell.2011.09.028
Zhu M, Liu J, Xiao J, Yang L, Cai M, Shen H, Chen X, Ma Y, Hu S, Wang Z, Hong A, Li Y, Sun Y, Wang X (2017) Lnc-mg is a long non-coding RNA that promotes myogenesis. Nat Commun 8:14718. https://doi.org/10.1038/ncomms14718
Zhang ZK, Li J, Guan D, Liang C, Zhuo Z, Liu J, Lu A, Zhang G, Zhang BT (2018) A newly identified lncRNA MAR1 acts as a miR-487b sponge to promote skeletal muscle differentiation and regeneration. J Cachexia Sarcopenia Muscle 9:613. https://doi.org/10.1002/jcsm.12281
Zhou L, Sun K, Zhao Y, Zhang S, Wang X, Li Y, Lu L, Chen X, Chen F, Bao X, Zhu X, Wang L, Tang LY, Esteban MA, Wang CC, Jauch R, Sun H, Wang H (2015) Linc-YY1 promotes myogenic differentiation and muscle regeneration through an interaction with the transcription factor YY1. Nat Commun 6:10026. https://doi.org/10.1038/ncomms10026
Militello G, Hosen MR, Ponomareva Y, Gellert P, Weirick T, John D, Hindi SM, Mamchaoui K, Mouly V, Doring C, Zhang L, Nakamura M, Kumar A, Fukada SI, Dimmeler S, Uchida S (2018) A novel long non-coding RNA Myolinc regulates myogenesis through TDP-43 and Filip1. J Mol Cell Biol 10:102. https://doi.org/10.1093/jmcb/mjy025
Wang L, Zhao Y, Bao X, Zhu X, Kwok YK, Sun K, Chen X, Huang Y, Jauch R, Esteban MA, Sun H, Wang H (2015) LncRNA Dum interacts with Dnmts to regulate Dppa2 expression during myogenic differentiation and muscle regeneration. Cell Res 25(3):335–350. https://doi.org/10.1038/cr.2015.21
Wang J, Gong C, Maquat LE (2013) Control of myogenesis by rodent SINE-containing lncRNAs. Genes Dev 27(7):793–804. https://doi.org/10.1101/gad.212639.112
Lu L, Sun K, Chen X, Zhao Y, Wang L, Zhou L, Sun H, Wang H (2013) Genome-wide survey by ChIP-seq reveals YY1 regulation of lincRNAs in skeletal myogenesis. EMBO J 32(19):2575–2588. https://doi.org/10.1038/emboj.2013.182
Ballarino M, Cazzella V, D’Andrea D, Grassi L, Bisceglie L, Cipriano A, Santini T, Pinnaro C, Morlando M, Tramontano A, Bozzoni I (2015) Novel long noncoding RNAs (lncRNAs) in myogenesis: a miR-31 overlapping lncRNA transcript controls myoblast differentiation. Mol Cell Biol 35(4):728–736. https://doi.org/10.1128/MCB.01394-14
Han X, Yang F, Cao H, Liang Z (2015) Malat1 regulates serum response factor through miR-133 as a competing endogenous RNA in myogenesis. FASEB J 29(7):3054–3064. https://doi.org/10.1096/fj.14-259952
Wang GQ, Wang Y, Xiong Y, Chen XC, Ma ML, Cai R, Gao Y, Sun YM, Yang GS, Pang WJ (2016) Sirt1 AS lncRNA interacts with its mRNA to inhibit muscle formation by attenuating function of miR-34a. Sci Rep 6:21865. https://doi.org/10.1038/srep21865
Penna F, Costamagna D, Fanzani A, Bonelli G, Baccino FM, Costelli P (2010) Muscle wasting and impaired myogenesis in tumor bearing mice are prevented by ERK inhibition. PLoS One 5(10):e13604. https://doi.org/10.1371/journal.pone.0013604
Lorson CL, Hahnen E, Androphy EJ, Wirth B (1999) A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proc Natl Acad Sci U S A 96(11):6307–6311
Lefebvre S, Burglen L, Reboullet S, Clermont O, Burlet P, Viollet L, Benichou B, Cruaud C, Millasseau P, Zeviani M et al (1995) Identification and characterization of a spinal muscular atrophy-determining gene. Cell 80(1):155–165
d’Ydewalle C, Ramos DM, Pyles NJ, Ng SY, Gorz M, Pilato CM, Ling K, Kong L, Ward AJ, Rubin LL, Rigo F, Bennett CF, Sumner CJ (2017) The antisense transcript SMN-AS1 regulates SMN expression and is a novel therapeutic target for spinal muscular atrophy. Neuron 93(1):66–79. https://doi.org/10.1016/j.neuron.2016.11.033
Woo CJ, Maier VK, Davey R, Brennan J, Li G, Brothers J 2nd, Schwartz B, Gordo S, Kasper A, Okamoto TR, Johansson HE, Mandefro B, Sareen D, Bialek P, Chau BN, Bhat B, Bullough D, Barsoum J (2017) Gene activation of SMN by selective disruption of lncRNA-mediated recruitment of PRC2 for the treatment of spinal muscular atrophy. Proc Natl Acad Sci U S A 114(8):E1509–E1518. https://doi.org/10.1073/pnas.1616521114
Haijun Z, Yonghui Y, Jiake C (2016) Expression signatures of lncRNAs in skeletal muscles at the early flow phase revealed by microarray in burned rats. Ulus Travma Acil Cerrahi Derg 22(3):224–232. https://doi.org/10.5505/tjtes.2015.04831
Acknowledgments
This work was supported by the grants from National Natural Science Foundation of China (81722008, 91639101 and 81570362 to JJ Xiao), Innovation Program of Shanghai Municipal Education Commission (2017-01-07-00-09-E00042 to JJ Xiao), the grant from Science and Technology Commission of Shanghai Municipality (17010500100 to JJ Xiao), and the development fund for Shanghai talents (to JJ Xiao).
Competing Financial Interests
The authors declare no competing financial interests.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Li, Y., Meng, X., Li, G., Zhou, Q., Xiao, J. (2018). Noncoding RNAs in Muscle Atrophy. In: Xiao, J. (eds) Muscle Atrophy. Advances in Experimental Medicine and Biology, vol 1088. Springer, Singapore. https://doi.org/10.1007/978-981-13-1435-3_11
Download citation
DOI: https://doi.org/10.1007/978-981-13-1435-3_11
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-1434-6
Online ISBN: 978-981-13-1435-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)